7th Apr 2006 16:33
GlaxoSmithKline PLC07 April 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 4 April 2006 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("the GSK Trust"), transferred 30,622 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. 5 April 2006 The GSK Trust transferred 6,252 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. 5 April 2006 The GSK Trust transferred 30,902 Ordinary Shares in the Company to participants in the GlaxoSmithKline Share Value Plan. 5 April 2006 The GSK Trust sold 7,196 Ordinary Shares in the Company on behalf of participants in the GlaxoSmithKline Share Value Plan at a price of £15.01. The Company was advised of these transactions on 6 April 2006. The GSK Trust is a discretionary trust of which all employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr T Yamada andMr J S Heslop are therefore interested in the shares held in the GSK Trust fromtime to time in the same way as other employees or former employees ofGlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 7 April 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline